The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...
from NDTV News - Topstories https://ift.tt/2FMnI1j
Subscribe to:
Post Comments (Atom)
Union Budget 2025: Markets not moved by FM playing taxophone
The Budget proposals led to a muted response on Dalal Street, with the Sensex closing slightly up and Nifty down. Extreme bullish sentiment ...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News http://bit.ly/2VEK8DU...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
No comments:
Post a Comment